Mass spectrometry-based analysis of IGF-1 and hGH

Handbook of Experimental Pharmacology

Volumn 195, Issue , 2010, Pages 201-207

  Thevis, Mario ^a   Bredehöft, Michael ^b   Kohler, Maxie ^b   Schänzer, Wilhelm ^b  

^a GERMAN SPORT UNIVERSITY COLOGNE   (Germany)

^b NONE

Author keywords

2D Gel Electrophoresis; Doping; Sport

Indexed keywords

HUMAN GROWTH HORMONE; SOMATOMEDIN C; RECOMBINANT PROTEIN;

DOPING; DRUG DETERMINATION; DRUG SCREENING; ELECTROSPRAY MASS SPECTROMETRY; HUMAN; LIQUID CHROMATOGRAPHY; MASS SPECTROMETER; PRIORITY JOURNAL; PROTEIN POLYMORPHISM; PROTEIN PROCESSING; REVIEW; TANDEM MASS SPECTROMETRY; TWO DIMENSIONAL GEL ELECTROPHORESIS; AMINO ACID SEQUENCE; MASS SPECTROMETRY; METHODOLOGY; MOLECULAR GENETICS;

AMINO ACID SEQUENCE; DOPING IN SPORTS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MASS SPECTROMETRY; MOLECULAR SEQUENCE DATA; RECOMBINANT PROTEINS;

EID: 77449105744     PISSN: 01712004     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-540-79088-4_9     Document Type: Review

References (22)

1. Bredehöft M, Schänzer W, Thevis M (2008) Quantification of human insulin-like growth factor-1 and qualitative detection of its analogues in plasma using liquid chromatography/electrospray ionisation tandem mass spectrometry. Rapid Commun Mass Spectrom 22:477-485
2. Gam LH, Tham SY, Latiff A (2003) Immunoaffinity extraction and tandem mass spectrometric analysis of human chorionic gonadotropin in doping analysis. J Chromatogr B Analyt Technol Biomed Life Sci 792:187-196
3. Gasthuys M, Alves S, Fenaille F, Tabet JC (2004) Simple identification of a cross-linked hemoglobin by tandem mass spectrometry in human serum. Anal Chem 76:6628-6634
4. Gasthuys M, Alves S, Tabet J (2005) N-terminal adducts of bovine hemoglobin with glutaralde-hyde in a hemoglobin-based oxygen carrier. Anal Chem 77:3372-3378
5. Giorgianni F, Beranova-Giorgianni S, Desiderio DM (2004) Identification and characterization of phosphorylated proteins in the human pituitary. Proteomics 4:587-598
6. Goebel C, Alma C, Howe C, Kazlauskas R, Trout G (2005) Methodologies for detection of hemoglobin-based oxygen carriers. J Chromatogr Sci 43:39-46
7. Hepner F, Cszasar E, Roitinger E, Lubec G (2005) Mass spectrometrical analysis of recombinant human growth hormone (Genotropin(R)) reveals amino acid substitutions in 2% of the expressed protein. Proteome Sci 3:1
8. Kohler M, Püschel K, Schänzer W, Thevis M (2007) Mass spectrometric identification of human pituitary growth hormone variants. In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds) Recent advances in doping analysis. Sport & Buch Strauß, Cologne, pp 21-30
9. Kohler M, Püschel K, Sakharov D, Tonevitskiy A, Schänzer W, Thevis M (2008) Detection of recombinant growth hormone in human plasma by a 2D-PAGE method. Electrophoresis 29:4495-4502
10. Kohler M, Thomas A, Püschel K, Schänzer W, Thevis M (2009) Identification of human pituitary growth hormone variants by mass spectrometry. J Proteome Res 8:1071-1076
11. Nelson RW, Nedelkov D, Tubbs KA, Kiernan UA (2004) Quantitative mass spectrometric immunoassay of insulin like growth factor 1. J Proteome Res 3:851-855
12. Popot MA, Bobin S, Bonnaire Y, Delahaut PH, Closset J (2001) IGF-I plasma concentrations in non-treated horses and horses administered with methionyl equine somatotropin. Res Vet Sci 71:167-173
13. Popot MA, Woolfitt AR, Garcia P, Tabet JC (2008) Determination of IGF-I in horse plasma by LC electrospray ionisation mass spectrometry. Anal Bioanal Chem 390:1843-1852
14. Thevis M, Schänzer W (2007) Current role of LC-MS(/MS) in doping control. Anal Bioanal Chem 388:1351-1358
15. Thevis M, Ogorzalek-Loo RR, Loo JA, Schänzer W (2003) Doping control analysis of bovine hemoglobin-based oxygen therapeutics in human plasma by LC-electrospray ionization-MS/MS. Anal Chem 75:3287-3293
16. Thevis M, Thomas A, Delahaut P, Bosseloir A, Schänzer W (2005) Qualitative determination of synthetic analogues of insulin in human plasma by immunoaffinity purification and liquid chromatography-tandem mass spectrometry for doping control purposes. Anal Chem 77: 3579-3585
17. Thevis M, Bredehöft M, Geyer H, Kamber M, Delahaut P, Schänzer W (2006a) Determination of Synacthen in human plasma using immunoaffinity purification and liquid chromatography/ tandem mass spectrometry. Rapid Commun Mass Spectrom 20:3551-3556
18. Thevis M, Thomas A, Delahaut P, Bosseloir A, Schänzer W (2006b) Doping control analysis of intact rapid-acting insulin analogues in human urine by liquid chromatography-tandem mass spectrometry. Anal Chem 78:1897-1903
19. Thevis M, Thomas A, Schänzer W (2008) Mass spectrometric determination of insulins and their degradation products in sports drug testing. Mass Spectrom Rev 27:35-50
20. Thomas A, Thevis M, Delahaut P, Bosseloir A, Schänzer W (2007) Mass spectrometric identification of degradation products of insulin and its long-acting analogues in human urine for doping control purposes. Anal Chem 79:2518-2524
21. Thomas A, Geyer H, Kamber M, Schanzer W, Thevis M (2008) Mass spectrometric determination of gonadotrophin-releasing hormone (GnRH) in human urine for doping control purposes by means of LC-ESI-MS/MS. J Mass Spectrom 43:908-915
22. Zhan X, Giorgianni F, Desiderio DM (2005) Proteomics analysis of growth hormone isoforms in the human pituitary. Proteomics 5:1228-1241